NasdaqGS - Delayed Quote • USD
Kamada Ltd. (KMDA)
At close: May 28 at 4:00 PM EDT
After hours: May 28 at 5:48 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 0.05 | 0.06 | 0.26 | 0.3 |
| Low Estimate | 0.05 | 0.05 | 0.25 | 0.22 |
| High Estimate | 0.06 | 0.07 | 0.27 | 0.39 |
| Year Ago EPS | 0.04 | 0.06 | 0.15 | 0.26 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 39.43M | 40.51M | 159.95M | 179.74M |
| Low Estimate | 38.87M | 39.93M | 159.9M | 175M |
| High Estimate | 40M | 41.1M | 160M | 184.48M |
| Year Ago Sales | 37.44M | 37.93M | 142.52M | 159.95M |
| Sales Growth (year/est) | 5.30% | 6.80% | 12.20% | 12.40% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.02 | 0.03 | 0.05 | 0.06 |
| EPS Actual | 0.04 | 0.06 | 0.09 | 0.04 |
| Difference | 0.02 | 0.03 | 0.04 | -0.02 |
| Surprise % | 100.00% | 100.00% | 80.00% | -33.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.05 | 0.06 | 0.26 | 0.3 |
| 7 Days Ago | 0.05 | 0.05 | 0.22 | 0.32 |
| 30 Days Ago | 0.06 | 0.06 | 0.22 | 0.41 |
| 60 Days Ago | 0.06 | 0.06 | 0.22 | 0.41 |
| 90 Days Ago | 0 | 0 | 0.28 | 0.55 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| CURRENCY IN USD | KMDA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 25.00% | -- | -- | 7.90% |
| Next Qtr. | 0.00% | -- | -- | 10.20% |
| Current Year | 73.30% | -- | -- | 4.80% |
| Next Year | 15.40% | -- | -- | 12.50% |
| Next 5 Years (per annum) | 6.00% | -- | -- | 11.27% |
| Past 5 Years (per annum) | -21.39% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/9/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/17/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/25/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 3/16/2023 |
Related Tickers
LFCR Lifecore Biomedical, Inc.
5.58
-0.71%
AMRX Amneal Pharmaceuticals, Inc.
6.79
+5.27%
COLL Collegium Pharmaceutical, Inc.
34.37
+0.35%
HCM HUTCHMED (China) Limited
19.15
+2.24%
TARO Taro Pharmaceutical Industries Ltd.
42.69
0.00%
PCRX Pacira BioSciences, Inc.
30.05
+1.21%
INCR InterCure Ltd.
3.2800
+3.47%
PBH Prestige Consumer Healthcare Inc.
63.18
-1.23%
HLN Haleon plc
8.39
+0.12%
IRWD Ironwood Pharmaceuticals, Inc.
5.88
-1.18%